首页> 外文期刊>World Journal of Gastroenterology >Proteomic profiling of fetal esophageal epithelium, esophageal cancer, and tumor-adjacent esophageal epithelium and immunohistochemical characterization of a representative differential protein, PRX6
【24h】

Proteomic profiling of fetal esophageal epithelium, esophageal cancer, and tumor-adjacent esophageal epithelium and immunohistochemical characterization of a representative differential protein, PRX6

机译:胎儿食管上皮,食管癌和肿瘤附近食管上皮的蛋白质组学分析以及代表性差异蛋白PRX6的免疫组织化学表征

获取原文
           

摘要

AIM To understand the molecular mechanism of esophageal cancer development and provide molecular markers for screening high-risk populations and early diagnosis. METHODS Two-dimensional electrophoresis combined with mass spectrometry were adopted to screen differentially expressed proteins in nine cases of fetal esophageal epithelium, eight cases of esophageal cancer, and eight cases of tumor-adjacent normal esophageal epithelium collected from fetuses of different gestational age, or esophageal cancer patients from a high-risk area of esophageal cancer in China. Immunohistochemistry (avidin-biotin-horseradish peroxidase complex method) was used to detect the expression of peroxiredoxin (PRX)6 in 91 cases of esophageal cancer, tumor-adjacent normal esophageal tissue, basal cell hyperplasia, dysplasia, and carcinoma in situ , as well as 65 cases of esophageal epithelium from fetuses at a gestational age of 3-9 mo. RESULTS After peptide mass fingerprint analysis and search of protein databases, 21 differential proteins were identified; some of which represent a protein isoform. Varying degrees of expression of PRX6 protein, which was localized mainly in the cytoplasm, were detected in adult and fetal normal esophageal tissues, precancerous lesions, and esophageal cancer. With the progression of esophageal lesions, PRX6 protein expression showed a declining trend ( P < 0.05). In fetal epithelium from fetuses at gestational age 3-6 mo, PRX6 protein expression showed a declining trend with age ( P < 0.05). PRX6 protein expression was significantly higher in well-differentiated esophageal cancer tissues than in poorly differentiated esophageal cancer tissues ( P < 0.05). CONCLUSION Development and progression of esophageal cancer result from interactions of genetic changes (accumulation or superposition). PRX6 protein is associated with fetal esophageal development and cancer differentiation.
机译:目的了解食管癌发展的分子机制,为筛选高危人群和早期诊断提供分子标记。方法采用二维电泳结合质谱技术对9例胎儿食管上皮,8例食管癌和8例不同胎龄或食管胎儿采集的肿瘤邻近正常食管上皮中的差异表达蛋白进行筛选。来自中国食管癌高危地区的癌症患者。免疫组化(抗生物素蛋白-生物素-辣根过氧化物酶复合法)检测过氧化物酶毒素(PRX)6在食管癌,肿瘤邻近的正常食管组织,基底细胞增生,异型增生和原位癌中的91例表达年龄在3-9 mo的胎儿食管上皮为65例。结果经过肽质量指纹图谱分析和蛋白质数据库搜索,鉴定出21种差异蛋白。其中一些代表蛋白质同工型。在成人和胎儿的正常食管组织,癌前病变和食道癌中检测到PRX6蛋白的表达程度主要位于细胞质中。随着食管病变的进展,PRX6蛋白表达呈下降趋势(P <0.05)。在胎龄为3-6 mo的胎儿胎上皮中,PRX6蛋白表达随年龄下降而下降(P <0.05)。高分化的食管癌组织中PRX6蛋白的表达明显高于低分化的食管癌组织中(P <0.05)。结论食管癌的发生和发展是基因变化(积累或叠加)相互作用的结果。 PRX6蛋白与胎儿食道发育和癌症分化有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号